Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis.

MLA

Gossec, Laure, et al. “Validity and Score Interpretation of the 12-Item Psoriatic Arthritis Impact of Disease: An Analysis of Pooled Data from Two Phase 3 Trials of Bimekizumab in Patients with Psoriatic Arthritis.” RMD Open, vol. 10, no. 1, Jan. 2024. EBSCOhost, https://doi.org/10.1136/rmdopen-2023-003548.

APA

Gossec, L., Orbai, A.-M., Coates, L. C., Gladman, D. D., Ogdie, A., Pelligra, C. G., Ciaravino, V., Ink, B., Taieb, V., Lambert, J., & de Wit, M. (2024). Validity and score interpretation of the 12-item Psoriatic Arthritis Impact of Disease: an analysis of pooled data from two phase 3 trials of bimekizumab in patients with psoriatic arthritis. RMD Open, 10(1). https://doi.org/10.1136/rmdopen-2023-003548

Chicago

Gossec, Laure, Ana-Maria Orbai, Laura C Coates, Dafna D Gladman, Alexis Ogdie, Christopher G Pelligra, Valérie Ciaravino, et al. 2024. “Validity and Score Interpretation of the 12-Item Psoriatic Arthritis Impact of Disease: An Analysis of Pooled Data from Two Phase 3 Trials of Bimekizumab in Patients with Psoriatic Arthritis.” RMD Open 10 (1). doi:10.1136/rmdopen-2023-003548.